Listen Top Shows Blog

Novo Nordisk pushes FDA to stop GLP1 compounding citing "complexity'

Novo Nordisk pushes FDA to stop GLP1 compounding citing "complexity'

Update: 2024-10-24

Share

Description

Today we discuss a major development: Novo Nordisk, the company behind WeGovy and Ozempic, is pushing the FDA to stop compounding pharmacies from manufacturing the compounded medications, citing the complexity of manufacture. Critics say it is just a ploy to secure profits.

Comments

In Channel

GLP1 Improving Heart Health

GLP1 Improving Heart Health

2024-11-2114:34

Rapid evolution of GLP-1: A Comprehensive Update

Rapid evolution of GLP-1: A Comprehensive Update

2024-11-1622:20

Ethics and Accessibility of GLP-1ra Long Term

Ethics and Accessibility of GLP-1ra Long Term

2024-11-1113:43

What This 2024 Presidential Election Means for GLP-1ra and Big Pharma

What This 2024 Presidential Election Means for GLP-1ra and Big Pharma

2024-11-0754:00

GLP1s - a deeper dive into how they work

GLP1s - a deeper dive into how they work

2024-11-0113:13

Current trends in weight loss: What's going on? What's the big picture?

Current trends in weight loss: What's going on? What's the big picture?

2024-10-2915:19

FDA reverses decision to halt compounding of Terzepetide, for now

FDA reverses decision to halt compounding of Terzepetide, for now

2024-10-2811:16

Big Pharma Grilled on GLP1 Pricing; Why are Ozempic and other drugs so expensive?

Big Pharma Grilled on GLP1 Pricing; Why are Ozempic and other drugs so expensive?

2024-10-2513:54

Novo Nordisk pushes FDA to stop GLP1 compounding citing "complexity'

Novo Nordisk pushes FDA to stop GLP1 compounding citing "complexity'

2024-10-2410:17

featured sponsor episode: tune-health

featured sponsor episode: tune-health

2024-10-2312:42

FDA warnings about adverse reactions to GLP1s due to common errors

FDA warnings about adverse reactions to GLP1s due to common errors

2024-10-2208:15

GLP1 and its positive benefit in reducing addictions

GLP1 and its positive benefit in reducing addictions

2024-10-2112:33

GLP1 Week in Review (10-20-2024)

GLP1 Week in Review (10-20-2024)

2024-10-2010:54

Common Mistakes People Make on GLP1 Protocols

Common Mistakes People Make on GLP1 Protocols

2024-10-1911:21

What Goes Into Manufacturing GLP-1

What Goes Into Manufacturing GLP-1

2024-10-1815:32

Effectiveness of Compounded Semaglutide

Effectiveness of Compounded Semaglutide

2024-10-1716:53

Insurance Coverage for Weight Loss Meds: Challenges & Opportunities

Insurance Coverage for Weight Loss Meds: Challenges & Opportunities

2024-10-1605:15

Successfully Fighting for Insurance Coverage & Major Insurers Covering GLP1

Successfully Fighting for Insurance Coverage & Major Insurers Covering GLP1

2024-10-1511:16

Denied Insurance Coverage? Steps you can take.

Denied Insurance Coverage? Steps you can take.

2024-10-1416:27

Weight Loss Drugs & Employer Coverage

Weight Loss Drugs & Employer Coverage

2024-10-1307:45

00:00

00:00

x

Novo Nordisk pushes FDA to stop GLP1 compounding citing "complexity'

Novo Nordisk pushes FDA to stop GLP1 compounding citing "complexity'